Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01429077 · ClinicalTrials.gov registry record · Phase 2

Augmenting Language Therapy for Aphasia: Levodopa

A Phase 2 study of Stroke and Nonfluent Aphasia, sponsored by Shirley Ryan AbilityLab.

Completed
Registry status
Phase 2
Development phase
36
Enrollment target
1
Study location

NCT01429077: Completed Phase 2 study of Stroke and Nonfluent Aphasia, sponsored by Shirley Ryan AbilityLab.

NCT01429077 is a Phase 2 study of Stroke and Nonfluent Aphasia that has completed, run by Shirley Ryan AbilityLab. The registered enrollment target is 36 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01429077, a Phase 2 study of Stroke and Nonfluent Aphasia, has completed, sponsored by Shirley Ryan AbilityLab.

COMPLETED
Registry status
Phase 2
Development phase
36 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to evaluate the effectiveness of the medication levodopa, in combination with speech-language treatment, on the language outcome of study subjects with nonfluent aphasia (i.e. difficulty with the comprehension and expression of spoken and written language) following a stroke.

Conditions Studied

Stroke Nonfluent Aphasia

Interventions

  • DRUG Placebo comparator
  • DRUG levodopa/carbidopa

Study Locations (1)

Illinois

  • Center for Aphasia Research & Treatment - Chicago

Trial Details

FieldValue
Enrollment Target 36 participants
Start Date 2007-10
Est. Completion 2012-03
Phase Phase 2

Sponsor

Shirley Ryan AbilityLab

138 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01429077

The ClinicalTrials.gov registry entry for NCT01429077 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The listed sponsor is Shirley Ryan AbilityLab, which has 138 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Stroke appearing as the primary indexed condition, and to 2 interventions - of which Placebo comparator is the first listed.

NCT01429077 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT01429077 about?

NCT01429077 is a clinical study titled "Augmenting Language Therapy for Aphasia: Levodopa". The purpose of this study is to evaluate the effectiveness of the medication levodopa, in combination with speech-language treatment, on the language outcome of study subjects with nonfluent aphasia (i.e. difficulty with the comprehension and expression of spoken and written language) following a st...

What is the current status of trial NCT01429077?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 36 participants. The study started on 2007-10. Estimated completion is 2012-03.

What conditions does trial NCT01429077 study?

This clinical trial studies the following conditions: Stroke, Nonfluent Aphasia.

What interventions are being tested in trial NCT01429077?

The interventions under investigation include: Placebo comparator (DRUG), levodopa/carbidopa (DRUG).

Who is sponsoring clinical trial NCT01429077?

This trial is sponsored by Shirley Ryan AbilityLab, which has 138 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01429077 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Stroke

All registered trials for this condition

Nonfluent Aphasia

All registered trials for this condition

Illinois

All trials with a study site in Illinois

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Related

Compare this shortlist side-by-side

Read our methodology - how this data is sourced, computed, and verified.
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.